Dr Reddy's received two USFDA observations at its Andhra Pradesh facility, highlighting the importance of Indian pharma GMP compliance and manufacturing quality.
NVIDIA-backed AI is powering Iambic Therapeutics’ cancer drug pipeline as the biotech prepares for an IPO targeting a valuation of USD 806 million.
Health Minister J.P. Nadda has launched JOSH Teams to boost TB elimination in India, putting fresh focus on drug demand, supply and access.
Akums unveils a palm-free peptide skincare range targeting winter dryness, skin-barrier support and evolving consumer demand for specialized moisturization.
Drug development faces mounting safety concerns, clinical setbacks, and pressure to modernize standards. Three industry moves reveal how pharma balances risk management with faster, more efficient development.
HPV shot before pregnancy may cut preterm birth risk, adding another potential benefit to established cancer prevention.
AIIMS Bathinda HIPEC unit expands specialised peritoneal cancer treatment and strengthens advanced cancer-care access across Punjab and neighbouring states.
Healthcare influencer marketing faces new NMC rules as agencies, influencers, and platforms navigate stricter advertising and patient procurement restrictions.
Novartis Rhapsido FDA approval adds the first targeted treatment for symptomatic dermographism, addressing persistent symptoms despite H1 antihistamines.
Granules’ 2,000 crore capex milestone strengthens its peptide CDMO push while accelerating complex generics, oncology, and higher-value pharmaceuticals.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
